Skip to content
Instalab logo

Instalab

Instalab is a YC Winter 2022 (W22) company. Based in New York, NY, USA.

  • Consumer Health Services
  • Health Tech
  • Telemedicine
  • Health & Wellness
  • AI

About Instalab

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Instalab builds a proactive health platform for founders, executives, and professional athletes who want to stay ahead of health issues rather than react to them. Members get access to 600-plus lab tests and imaging studies, personalized health reports, physician-guided medications, and evidence-based supplements, all in one place. The platform replaces the fragmented process of coordinating between primary care, labs, imaging centers, and specialists.

Business model

Instalab+ subscription plan, with individual tests, medications, and supplements available à la carte.

Go-to-market

High-performing professionals are the core buyer; they start via self-serve sign-up on the website, with optional physician consultations available on demand.

From the Y Combinator listing

How Instalab describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Proactive Testing and Treatments

Instalab gives you direct access to all the preventative tests you need to do this year to stay on top of your health. Trusted by tens of thousands of top-performing founders, executives, and professional athletes.

Facts

Industry
Healthcare / Healthcare -> Consumer Health and Wellness
Location
New York, NY, USA
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works